Orthopedic Soft Tissue Repair Market By Procedure (Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapse, Gluteal Tendon Repair, Cruciate Ligaments Repair, Hip Arthroscopy, Biceps Tenodesis ), By Therapeutic Site (Knee, Shoulder, Hip ) - Growth, Future Prospects & Competitive Analysis, 2017- 2025

Orthopedic soft tissue repair products are used for reinforcement of weak, damaged or ruptured soft tissue. The growth of this market is mainly contributed by factors such as easy availability of novel products, increasing incidence of sports-related injuries, significant growth in highly vulnerable geriatric population. The demand for orthopedic soft tissue repair products will be the highest in Asia Pacific market mainly due to large target population and untapped market penetration opportunities. Conversely, lack of reimbursement policies, and high cost of these products and related procedures may restrain the growth of this market during the forecast period.

The purpose of this research study titled ‘Orthopedic Soft Tissue Repair Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global orthopedic soft tissue repair market. This report presents and analyzes the major trends prevalent in the global orthopedic soft tissue repair market and the market size and forecast.

This report categorizes the global orthopedic soft tissue repair market in terms of procedure type, therapeutic site, and geographical distribution. Based on procedure type, the global orthopedic soft tissue repair market is categorized into rotator cuff repair, epicondylitis, achilles tendinosis repair, pelvic organ prolapse, gluteal tendon repair, cruciate ligaments repair, hip arthroscopy, biceps tenodesis, and others. Knee, shoulder, hip and other locations are the therapeutic sites considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global orthopedic soft tissue repair market is best understood by segmenting the market into five major regions and chief region level markets as follows:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa
  •  

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms procedure type, therapeutic site and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global orthopedic soft tissue repair market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the orthopedic soft tissue repair market. The key players profiled in this report are Acera Surgical Inc., AlloSource, ArthroCare Corporation, Arthrex Inc., Conmed Corporation, DePuy Synthes, LifeNet Health Inc., Smith and Nephew plc, Stryker, Tornier and Zimmer Biomet Holdings, Inc.

North America and Europe collectively dominate the global orthopedic soft tissue repair market with a combined market share of over 55%. Existence of several major market incumbents in North America and Western Europe along with swift availability of innovative treatment solutions mainly drive the demand in these regions. Greater purchasing power of domestic patient population and evolved reimbursements also contribute to the dominance of North America and Europe. Growing awareness, existence of huge target population base, growing skills among surgeons and are expected to drive the Asia Pacific market, making it the fastest progressing regional market on the global front.